R4758

Resorufin β-D-glucopyranoside

Name: Resorufin β-<SC>D</SC>-glucopyranoside
Brand: SIGMA

≥90%, powder

Sinónimos:

3-Phenoxazone 7-(β-D-glucopyranoside)

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Todas las fotos(1)

About This Item

Fórmula empírica (notación de Hill):

C₁₈H₁₇NO₈

Número CAS:

101490-85-1

Peso molecular:

375.33

NACRES:

NA.32

PubChem Substance ID:

24899374

UNSPSC Code:

12352204

MDL number:

MFCD00037662

Beilstein/REAXYS Number:

4335306

Nombre del producto

Resorufin β-D-glucopyranoside, ≥90%

InChI

1S/C18H17NO8/c20-7-14-15(22)16(23)17(24)18(27-14)25-9-2-4-11-13(6-9)26-12-5-8(21)1-3-10(12)19-11/h1-6,14-18,20,22-24H,7H2/t14-,15-,16+,17-,18-/m1/s1

SMILES string

OC[C@H]1O[C@@H](Oc2ccc3N=C4C=CC(=O)C=C4Oc3c2)[C@H](O)[C@@H](O)[C@@H]1O

InChI key

QULZFZMEBOATFS-UYTYNIKBSA-N

assay

≥90%

form

powder

solubility

DMSO: 20 mg/mL

storage temp.

−20°C

Quality Level

200

¿Está buscando productos similares? Visita Guía de comparación de productos

Application

Resorufin β-D-glucopyranoside has been used:

as a substrate to determine the kinetics properties for Clostridium cellulovorans (CcBglA), the fungus Trichoderma reesei (TrBgl2), and the termite Neotermes koshunensis (NkBg)
as a chromogenic β-glucopyranoside for screening studies
as a fluorogenic substrate to determine the glucocerebrosidase enzyme activity in substantia nigra

Clase de almacenamiento

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

0000511538

0000357367

0000278640

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

Busque por un COA

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels.

Anna Lisa Gündner et al.

Neurobiology of disease, 121, 205-213 (2018-09-22)

Synucleinopathies including Parkinson's disease (PD) and Dementia with Lewy bodies (DLB) are characterized by the accumulation of abnormal α-synuclein in intraneuronal inclusions, named Lewy bodies. Mutations in GBA1, the gene encoding the lysosomal hydrolase glucocerebrosidase, have been identified as the

Structural and functional analysis of three β-glucosidases from bacterium Clostridium cellulovorans, fungus Trichoderma reesei and termite Neotermes koshunensis.

Wen-Yih Jeng et al.

Journal of structural biology, 173(1), 46-56 (2010-08-05)

β-glucosidases (EC 3.2.1.21) cleave β-glucosidic linkages in disaccharide or glucose-substituted molecules and play important roles in fundamental biological processes. β-Glucosidases have been widely used in agricultural, biotechnological, industrial and medical applications. In this study, a high yield expression (70-250 mg/l)

Focused directed evolution of β-glucosidases: theoretical versus real effectiveness of a minimal working setup and simple robust screening.

Pavel Mazura et al.

Carbohydrate research, 346(2), 238-242 (2010-12-15)

Here we present an optimized procedure to generate amino acid variations at specific site(s) of proteins, followed by a simple one-step screen for mutants with the desired β-glucosidase activity. The procedure was evaluated by introducing sequence variation into a codon